April 22, 2011 -- Mid*Lands Institutional Review Board Announces Name Change to MidLands Independent Review Board (MLIRB), New Logo, and Launches New Website April 22, 2011 (Overland Park, KS) Mid*Lands IRB today announces the change of the company’s name to MidLands Independent Review Board (MLIRB), to reflect its positioning as an innovative Independent Review Board focused on the advancement of human subjects’ protection.
As part of its overall updated corporate identity, MLIRB also unveiled a new corporate logo. MLIRB also announces the launch of its completely redesigned website: www.MLIRB.com, as another integral component of its corporate identity update.
The new website is designed to be a comprehensive resource for clients, prospective corporate partners, and the clinical research community to learn more about MLIRB.
“We believe that MLIRB is well positioned to continue to service the needs of our diverse and growing client base, as well as dedicated to the appropriate growth of our business,” said Cathy Owen, CIM, CIP, CCRP, President and Chief Executive Officer of MLIRB.
“MLIRB’s full AAHRPP accreditation in 2010 was the first significant step in that process. Our name change, updated logo, and new website launch reflect the evolution of our business and ramp-up for the future needs of our clients. We have a new name, new logo, and new website, but at our core, our mission remains at the forefront – ‘Here to Protect What’s Important in Life.’”
About MLIRB
MLIRB, LLC is an AAHRPP fully-accredited Independent Review Board located in the Kansas City metro area. Focusing on protecting the rights and welfare of research study participants, MLIRB specializes in providing customized, personalized, and responsive services for its client partners.
Founded in 1981, MLIRB provides IRB review for clients nationwide for all phases of research in all therapeutic areas. MLIRB has extensive experience in multi-site trials, with two Boards that meet weekly. MLIRB offers on-demand Informed Consent development services, and its FDA Audit History is clear - no 483 ever issued.
For more information about MLIRB, please visit our website at www.MLIRB.com or contact:
Cathy Owen, CIM, CIP, CCRP, President & CEO, 913-385-1414, cathyo@midlandsirb.com.
